ADMA Biologics, Inc.ADMANASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+102.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+102.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.3x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$292.77M+33.3%
2024$219.55M+146.8%
2023$88.94M+152.2%
2022$35.27M+2906.4%
2021$1.17M+106.2%
2020$-19.07M-87.8%
2019$-10.16M+59.7%
2018$-25.21M-293.7%
2017$-6.40M-248.9%
2016$4.30M-